LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$61.87

Market cap

$3.31B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.01

Enterprise value

$3.36B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's quick ratio has surged by 182% QoQ and by 38% YoY
LivaNova's EPS has surged by 77% YoY and by 25% QoQ
LIVN's debt has soared by 78% since the previous quarter but it is down by 30% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: NVRO OFIX NUVA

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
53.44M
Market cap
$3.31B
Enterprise value
$3.36B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.55
Price to sales (P/S)
3.21
EV/EBIT
N/A
EV/EBITDA
233.47
EV/Sales
3.26
Earnings
Revenue
$1.03B
EBIT
-$50.19M
EBITDA
$14.37M
Free cash flow
$86.41M
Per share
EPS
-$2.01
Free cash flow per share
$1.62
Book value per share
$24.25
Revenue per share
$19.29
TBVPS
$21.2
Balance sheet
Total assets
$2.42B
Total liabilities
$1.13B
Debt
$491.44M
Equity
$1.29B
Working capital
$501.71M
Liquidity
Debt to equity
0.38
Current ratio
2.63
Quick ratio
2.03
Net debt/EBITDA
3.41
Margins
EBITDA margin
1.4%
Gross margin
69%
Net margin
-10%
Operating margin
1.3%
Efficiency
Return on assets
-4.5%
Return on equity
-8.4%
Return on invested capital
-9.1%
Return on capital employed
-2.4%
Return on sales
-4.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
0.37%
1 week
-0.96%
1 month
-11.46%
1 year
-24.96%
YTD
-29.23%
QTD
-0.96%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.03B
Gross profit
$709.75M
Operating income
$13.14M
Net income
-$103.13M
Gross margin
69%
Net margin
-10%
The company's operating income has surged by 105% YoY
LivaNova's operating margin has surged by 104% YoY
LIVN's net margin has soared by 77% year-on-year and by 24% since the previous quarter
The net income has soared by 75% YoY and by 24% from the previous quarter

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
P/E
N/A
P/B
2.55
P/S
3.21
EV/EBIT
N/A
EV/EBITDA
233.47
EV/Sales
3.26
LivaNova's EPS has surged by 77% YoY and by 25% QoQ
The price to book (P/B) is 27% lower than the last 4 quarters average of 3.5 and 6% lower than the 5-year quarterly average of 2.7
The equity rose by 21% year-on-year
The price to sales (P/S) is 22% lower than the last 4 quarters average of 4.1 and 14% lower than the 5-year quarterly average of 3.7
LivaNova's revenue has increased by 9% YoY

Efficiency

How efficient is LivaNova business performance
LivaNova's return on sales has surged by 86% YoY and by 32% QoQ
The return on equity has surged by 76% year-on-year and by 27% since the previous quarter
The company's return on assets has surged by 74% YoY and by 24% QoQ
The ROIC has soared by 66% YoY and by 23% from the previous quarter

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 115% higher than its total liabilities
LivaNova's quick ratio has surged by 182% QoQ and by 38% YoY
The current ratio has surged by 171% since the previous quarter and by 12% year-on-year
LIVN's debt is 62% smaller than its equity
LIVN's debt to equity has surged by 81% since the previous quarter but it is down by 42% year-on-year
LIVN's debt has soared by 78% since the previous quarter but it is down by 30% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.